BridgeBio Pharma Inc at UBS Global Healthcare Virtual Conference Transcript
I'm Ellie Merle. I'm one of the biotech analysts here at UBS. Thanks so much for joining us at the UBS Healthcare Conference. Very happy to have Neil Kumar, CEO and Founder of BridgeBio here with us today for a fireside chat. And with that, I'll turn it over to Neil.
Questions & Answers
Maybe taking a step back, can you sort of frame for us the business model and philosophy of BridgeBio's structure and how this could sort of increase R&D returns? And then kind of high-level, sort of what your key priorities are over the next couple of years?
Sure. Well, first of all, thanks so much for having me here. It's great to speak with you. Can you hear me okay, by the way, is it crystal clear to -- okay. Wonderful. So the BridgeBio business model is actually quite simple. It's something that we set up to
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
